The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
- 1 October 1991
- journal article
- clinical trial
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 52 (1) , 35-84
- https://doi.org/10.1016/0163-7258(91)90086-2
Abstract
No abstract availableKeywords
This publication has 411 references indexed in Scilit:
- VAD‐based regimens as primary treatment for multiple myelomaAmerican Journal of Hematology, 1990
- Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladderCancer, 1990
- Altered phenytoin clearance during intensive chemotherapy for acute lymphoblastic leukemiaThe Journal of Pediatrics, 1988
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Taxol-induced neuropathy: short-term effects of local injectionJournal of Neurocytology, 1984
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinomaCancer, 1979
- Overdosage with vincristineThe Journal of Pediatrics, 1976
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975
- [3H]-Vincristine. Preparation and preliminary pharmacologyJournal of Medicinal Chemistry, 1972